Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Regulus Therapeutics Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 26 | 45 | +19 |
| Shares | 11.1M | 52.1M | +41.0M (+368.7%) |
| Value | $14.2M | $147.3M | +$133.1M (+935.3%) |
New holders (22)
Institutions that held Regulus Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (3)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 28,461 | $36.4K |
| Bank of America Corp | 11 | $14 |
| Acadian Asset Management LLC | 466 | $0 |